Resources

Publish Date
Public Comments
C4IP Comments RE: Setting and Adjusting Patent Fees During Fiscal Year 2025 (PTO-P-2022-0033)
Council for Innovation Promotion
Letters
C4IP Letter to Senate Judiciary Committee RE: May 21, 2024 Hearing on Drug Prices
Council for Innovation Promotion
Letters
C4IP Letter to Senate Commerce, Science, & Transportation Committee RE: The Invent Here, Make Here Act of 2023
Council for Innovation Promotion
Public Comments
C4IP Comments RE: Inventorship Guidance for AI-Assisted Inventions (PTO-P-2023-0043)
Council for Innovation Promotion
Public Comments
C4IP Comments RE: Unlocking the Full Potential of Intellectual Property by Translating More Innovation to the Marketplace (PTO-C-2024-0004)
Council for Innovation Promotion
Public Comments
C4IP Comments RE: Motion to Amend Practice and Procedures in Trial Proceedings Under the America Invents Act Before the Patent Trial and Appeal Board (PTO-P-2020-0060)
Council for Innovation Promotion
Issue Briefs
What IP Experts Are Saying About the Biden Administration’s Draft Framework for March-In Rights
Council for Innovation Promotion
Congressional Innovation ScorecardReports
The Congressional Innovation Scorecard: First Edition
Council for Innovation Promotion
Public Comments
C4IP Comments RE: Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights
Council for Innovation Promotion
Letters
C4IP Letter to Senate Judiciary Subcommittee on Intellectual Property RE: PERA
Council for Innovation Promotion
Letters
Former Commerce Officials Letter to President Biden RE: March-in Rights
Council for Innovation Promotion
Public Comments
C4IP Comments RE: Implications of Access and Benefit Sharing (ABS) Commitments/Regimes and Other Proposed Commitments in the WHO Pandemic Agreement
Council for Innovation Promotion
Resources:

Resources:

C4IP Comments RE: Setting and Adjusting Patent Fees During Fiscal Year 2025 (PTO-P-2022-0033),

06/03/2024

Resources:

Resources:

C4IP Letter to Senate Judiciary Committee RE: May 21, 2024 Hearing on Drug Prices,

05/20/2024

Resources:

Resources:

C4IP Letter to Senate Commerce, Science, & Transportation Committee RE: The Invent Here, Make Here Act of 2023,

05/15/2024

Resources:

Resources:

C4IP Comments RE: Inventorship Guidance for AI-Assisted Inventions (PTO-P-2023-0043),

05/13/2024

Resources:

Resources:

C4IP Comments RE: Unlocking the Full Potential of Intellectual Property by Translating More Innovation to the Marketplace (PTO-C-2024-0004),

05/13/2024

Resources:

Resources:

C4IP Comments RE: Motion to Amend Practice and Procedures in Trial Proceedings Under the America Invents Act Before the Patent Trial and Appeal Board (PTO-P-2020-0060),

05/03/2024

Resources:

Resources:

What IP Experts Are Saying About the Biden Administration’s Draft Framework for March-In Rights,

04/09/2024

Resources:

Resources:

The Congressional Innovation Scorecard: First Edition,

03/21/2024

Resources:

Resources:

C4IP Comments RE: Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights,

02/06/2024

Resources:

Resources:

C4IP Letter to Senate Judiciary Subcommittee on Intellectual Property RE: PERA,

02/06/2024

Resources:

Resources:

Former Commerce Officials Letter to President Biden RE: March-in Rights,

02/02/2024

Resources:

Resources:

C4IP Comments RE: Implications of Access and Benefit Sharing (ABS) Commitments/Regimes and Other Proposed Commitments in the WHO Pandemic Agreement,

01/30/2024

Scroll to Top